Search Results

You searched for : Farxiga

	Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease... Jun 28
	The FDA has approved Farxiga to AstraZeneca to help protect kidney patients Chronic Kidney Disease needs attention and early intervention to protect the kidney from dialysis. The FDA has approved Farxiga to AstraZeneca to help protect kidney ... May 07
	Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease Farxiga could become the first SGLT2 inhibitor approved to treat patients with chronic kidney disease, with and without type-2 diabetes... Jan 06
	AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined For roxadustat, more than 40 abstracts present safety and efficacy outcomes in anaemia of chronic kidney disease ... Oct 20
	Early-stage data on Astra Zeneca COVID vaccine due Monday: Lancet Early-stage human trial data on a vaccine being developed by AstraZeneca and Oxford University will be published on July 20. ... Jul 17
5 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease

The FDA has approved Farxiga to AstraZeneca to help protect kidney patients

Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease

AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined

Early-stage data on Astra Zeneca COVID vaccine due Monday: Lancet

Trending Now